ArticleCellular oncology (Dordrecht, Netherlands)2023

Repurposing ketotifen as a therapeutic strategy for neuroendocrine prostate cancer by targeting the IL-6/STAT3 pathway.

Yiyi Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.